Pulling SEC filings + quote and writing the call…

EVERTEC, Inc.
Next earnings Jul 28, 2026 (after close) · consensus $0.97 EPS, $267M rev
Last earnings -0.8% on 2026-05-06
Cheap, cash-generative LatAm payments compounder at 12.5x earnings with double-digit growth — the discount overpays for known concentration risk.
P/E (price / FY diluted EPS $2.20) 12.5 · FY2025
Quality fundamentals and an attractive price line up (~182% below fair value) — the rarer case where both the business and the entry look good.
EVERTEC is a high-quality, capital-light payments and transaction-processing franchise (merchant acquiring, the ATH debit network, core-bank processing) spanning 26 countries, and the numbers show a business compounding nicely: FY2025 revenue grew 10.2% to $932M — capping a clean multi-year ramp from $590M in 2021 — while diluted EPS jumped 27.2% to $2.20 and net income rose 25.7% to $142M. Profitability is genuinely good: a 20.0% operating margin, 15.2% net margin, and a 22.8% return on equity, with capex of just $23.3M against $227M of operating cash flow underscoring management's 'recurring revenue, scalability, moderate capex' description. The stock trades at 12.5x earnings and 1.8x sales — undemanding for a recurring-revenue fintech growing double digits, especially with ~$204M of free cash flow against a $1.70B market cap (roughly a 12% FCF yield).
The valuation gap exists for identifiable reasons, and they are real but not disqualifying. Customer concentration is the headline risk the 10-K flags first: ~29% of FY2025 revenue came from Banco Popular, and the most significant contract — the A&R MSA — expires in 2028, with the filing explicitly warning Popular 'may require significant concessions… with respect to pricing, services, and other key terms.' That renewal, plus heavy exposure to Puerto Rico and Latin American macro/FX, is what keeps the multiple compressed. Leverage is also elevated at 2.46x liabilities/equity with $1.05B of long-term debt, though $306M of cash and $186M of operating income make it serviceable, and equity grew 31.6% as retained earnings build.
Is EVTC a buy? The one-page verdict, explained →
High-conviction BUY: a wider spread keeps more of the upside while the short call still cuts cost and decay.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $590M | $618M | $695M | $845M | $932M |
| Gross profit | — | — | — | — | — |
| Operating income | $197M | $157M | $136M | $166M | $186M |
| Net income | $161M | $239M | $79.7M | $113M | $142M |
| Diluted EPS | $2.21 | $3.45 | $1.21 | $1.73 | $2.20 |
| Net margin | 27.3% | 38.6% | 11.5% | 13.3% | 15.2% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Other-events 8-K (press release/corporate update); no clear material financial change
Disclosed 2026 annual meeting voting results; routine governance outcome
Entered a material definitive agreement (likely financing); terms filed as exhibit
Q1 2026: double-digit growth continues, margins and EPS expanding
Q1 2026 earnings release amid sustained double-digit revenue and EPS growth
Reg FD disclosure (investor presentation/guidance); no financial restatement
Reg FD disclosure (investor presentation/guidance); no financial restatement
2026 proxy: director slate, exec pay and auditor put to shareholder vote
FY2025: revenue $932M (+10%), EPS $2.20 (+27%); Popular still ~29% of revenue
Sources: SEC EDGAR (CIK 0001559865, latest 10-Q filed 2026-05-07) · EODHD · Proprietary analysis · as of 6/30/2026, 9:30:02 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 5:30 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 1 open-market buy · 0 sales
| 2026-06-12 | SMITH BRIAN JOHN Director | Buy | 16.2K @ $26.42 | $428K |
| 2026-06-03 | Pagan Ivan Director | Tax | 822.00 @ $25.11 | $20.6K |
| 2026-05-21 | SMITH BRIAN JOHN Director | Award | 10.3K @ $24.65 | $255K |
| 2026-05-21 | SCHUMACHER ALAN H Director | Award | 7.00K @ $24.65 | $172K |
| 2026-05-21 | Polak Aldo J. Director | Award | 7.00K @ $24.65 | $172K |
| 2026-05-21 | Pagan Ivan Director | Award | 7.00K @ $24.65 | $172K |
| 2026-05-21 | JUNQUERA JORGE A Director | Award | 10.3K @ $24.65 | $255K |
| 2026-05-21 | Gambale Virginia Director | Award | 7.00K @ $24.65 | $172K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.